Health Incubator Helsinki companies have once again succeeded in the selection process for Business Finland and Mayo Clinic’s market entry program, AMPlify.

The U.S. accounts for around 40% of the global healthcare market, and more than 30% of new technologies are developed in collaboration with international partners. This makes the U.S. a major opportunity for Finnish health startups – but how can they get there?

To accelerate Finnish health tech companies’ entry into the U.S. market, Business Finland has launched a new collaboration model through the AMPlify program in partnership with Mayo Clinic, one of the leading hospitals in the U.S. The program offers tailored support, connections to key stakeholders in the U.S. healthcare ecosystem, and culminates in a visit to Mayo Clinic’s headquarters in Minnesota.

Five Health Incubator Helsinki teams selected so far

For the newest batch of the AMPlify program, 11 companies have been selected, including three startups from Health Incubator Helsinki:

• NADMED, which has brought to market a novel NAD measurement technology.
• MultivisionDx, developing a tool to support the selection of the right cancer treatment.
• Otos, which aims to streamline complex hearing diagnostic procedures with its Otoscreen technology.

Health Incubator Helsinki was also represented in the first AMPlify cohort, with Solid IO and CurifyLabs joining the program last year.

Congratulations from the Health Incubator Helsinki team!

Read more about the AMPlify program.